**Abstract**

Disturbed sleep_ENREF_23_ENREF_23 has been \_ENREF_27 associated with increased insulin resistance in previous studies and there is growing body of evidence that activation of inflammatory pathways plays a crucial role in the development of insulin resistance. This study aimed to examine associations between objectively measured sleep, inflammatory markers and insulin resistance.

Cross-sectional data collected from 2004 to 2009 during the Midlife Development in the U.S. II (MIDUS II) biomarker project were used. The study was performed in the MIDUS Research Center at the University of Wisconsin--Madison and participants' homes. The study population included 374 community-based midlife subjects (138 men and 236 women) who completed 7 nights of wrist actigraphy. The mean age was 54.3 years (range 34 to 83).

To reveal factors associated with insulin resistance and age, statistically significant variables in univariate regression analyses were entered into multivariate regression analyses. Insulin resistance was estimated by homeostasis model assessment of insulin resistance (HOMA-IR). In women, higher sleep onset latency (SOL) was associated with higher insulin resistance after adjustment for possible confounding factors including age, smoking, obesity, diabetes, depression, and inflammatory cytokines. Also, higher SOL was associated with higher interleukin (IL)-6 and C-reactive protein (CRP) levels. After adjusting for covariates, no sleep measures were associated with insulin resistance, IL-6, or CRP in men. The mediation analysis showed that higher SOL is associated with insulin resistance both directly and indirectly.

Difficulty initiating sleep contributes to insulin resistance development, especially in middle-aged women. A combination of inflammatory pathway activation and physiological hyperarousal may be one of the key underlying mechanisms.
